Loading...

4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Alzheimer's Association International Conference 2026

July 12-15, 2026 | London, United Kingdom, and Online

Alzheimer's Association International Conference 2026 banner

12887

Multimorbidity Analysis Of The CogNID Study Population

Part of Topic

Basic Science and Pathogenesis -> Human Neuropathology -> Mixed pathology/comorbidities

INTRODUCTION

The Cognitive and Neuroimaging for Neurodegenerative Disorders (CogNID) database is a prospective cohort of memory clinic patients with mild cognitive impairment (MCI) or early dementia, seen between 2018- 2026.

Of 720 participants, 495 were included in this analysis: MCI without known cause (n=49), Alzheimer’s disease (AD, n=147), other neurodegenerative conditions (Other_ND, including FTD, DLB, VaD, n=135) and subjective cognitive decline (SCD, controls, n=164).

Aim: do modifiable risk factors differ across dementia subtypes and severity, and do risk factor profiles differ between YOD <65 and LOD, ≥65 years.

METHODS

 

Data were extracted from the CogNID database and analysed using R (version 4.5.2). Missing data were addressed using multiple imputation by chained equations (MICE).

Hierarchical multinomial logistic regression models were fitted to examine associations between modifiable risk factors (HTN, DM, CVD, stroke/TIA, depression, smoking, alcohol use and education) and diagnostic group, with controls as the reference category, and an age stratification added to compare young and late-onset groups.

Ordinal and linear regression examined ACE-III performance and multimorbidity burden was compared by ANOVA & Tukey post-hoc correction.

RESULTS 

Mean age differed significantly across groups, from 56 years in SCD to 63 years in AD-related MCI (p<0.001). Education level differed significantly (p=0.035), with the highest proportion of higher education in the AD group (30%).

CVD was the strongest predictor of Other_ND classification in both YOD (OR 3.93, p=0.005) and LOD (OR 5.08, p=0.16). Depression was the strongest modifiable predictor of worse cognitive performance in both YOD (-5.9 points, p=0.002) and LOD (-9.7 points, p=0.002).

 

CONCLUSIONS

Cardiovascular disease and depression emerged as key modifiable factors associated with non-AD neurodegeneration and cognitive performance, respectively.

Educational attainment showed a consistent protective association across all groups, supporting the cognitive reserve hypothesis.

AD was associated with significantly lower multimorbidity burden than all other diagnostic groups (vs control: -0.82, p<0.001; vs MCI: -0.86, p=0.003; vs Other_ND: -0.83, p<0.001) replicated across both young- and late-onset groups, suggests a distinct disease-driven process rather than an ageing effect alone (Figure 3).

Further work will focus on studying environmental risk factors, including air pollution, within the CogNID population. A limitation where the small MCI group had unknown longitudinal progression will also be addressed by further investigations.

 

REFERENCES

 

1.Mostert CM, Udeh-Momoh C, Winkler AS, McLaughlin C et al. Broadening dementia risk models: building on the 2024 Lancet Commission report for a more inclusive global framework. EBioMedicine. 2025 Oct;120:105950.
2.Hosseini AA, Shao B, Lee A et al. Cognitive and Neuroimaging for Neurodegenerative Disorders: A Cohort Study Design with Initial Findings. Front Psychiatry. 2025 Oct 29;16:1630082.
3.R Core Team. R: A Language and Environment for Statistical Computing. R Foundation, 2025.

Abbreviations: FTD (frontotemporal dementia), DLB (dementia with Lewy bodies), VaD (Vascular dementia), YOD (young onset dementia), LOD (late onset dementia), HTN  (hypertension), DM (type 2 diabetes), CVD (cardiovascular disease), ACE (Addenbrooke’s cognitive examination

Comments

Email is required but is not shown publicly.

Loading comments...

aaic2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.